ACOG Clinical Consensus No. 3: General Approaches to Medical Management of Menstrual Suppression

University of California, Davis, Sacramento, California

Financial Disclosure Dr. Creinin received a speaking honorarium from Gedeon Richter, Mayne, and Organon. He served on the Advisory Board for Evofem, Fuji Pharma, Gedeon Richter, GlaxoSmithKline, Mayne, Merck, OLIC, Organon, Searchlight, and TherapeuticsMD. He has been a consultant for Danco, Estetra SRL, FHI360, Libbs, Mayne, and Medicines360. The Department of Obstetrics and Gynecology, University of California, Davis, received contraceptive research funding for Dr. Creinin from Chemo Research SL, Evofem, HRA Pharma, Medicines360, Merck, and Sebela.

留言 (0)

沒有登入
gif